G Medical Innovations Holdings (G Medical Innovations Holdings) Total Stockholders Equity : $-7.35 Mil (As of Dec. 2022)

View and export this data going back to 2017. Start your Free Trial

What is G Medical Innovations Holdings Total Stockholders Equity?

G Medical Innovations Holdings's Total Stockholders Equity for the quarter that ended in Dec. 2022 was $-7.35 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. G Medical Innovations Holdings's Book Value per Share for the quarter that ended in Dec. 2022 was $-4.80. The ratio of a company's debt over equity can be used to measure how leveraged this company is. G Medical Innovations Holdings's Debt-to-Equity for the quarter that ended in Dec. 2022 was -0.28.

G Medical Innovations Holdings Total Stockholders Equity Historical Data

The historical data trend for G Medical Innovations Holdings's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G Medical Innovations Holdings Total Stockholders Equity Chart

G Medical Innovations Holdings Annual Data

Trend

Sep16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Stockholders Equity

Get a 7-Day Free Trial

-6.59

-13.38

-6.30

-6.03

-7.35

G Medical Innovations Holdings Semi-Annual Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22
Total Stockholders Equity	Get a 7-Day Free Trial							-6.30	3.38	-6.03	-4.19	-7.35

G Medical Innovations Holdings (OTCPK:GMVDF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

G Medical Innovations Holdings's Book Value per Share for the quarter that ended in Dec. 2022 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-7.353	-	0)	/	1.53279
	=	-4.80

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

G Medical Innovations Holdings's Debt-to-Equity for the quarter that ended in Dec. 2022 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.809	+	0.283)	/	-7.353
	=	-0.28

G Medical Innovations Holdings Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of G Medical Innovations Holdings's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

G Medical Innovations Holdings (G Medical Innovations Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » G Medical Innovations Holdings Ltd (OTCPK:GMVDF) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

5 Oppenheimer Street, Rehovot, ISR, 7670105

Website

https://www.gmedinnovations.com

G Medical Innovations Holdings Ltd is a mobile health (mHealth), telemedicine solutions, and monitoring service platforms. It develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. The company offers a suite of both consumer and clinical grade products and platforms which are positioned to reduce inefficiencies in healthcare delivery, improve access, reduce costs, increase the quality of care, and make healthcare more personalized and precise. Its operating segment includes Products, Patient Services, and Covid-19 testing. The company generates maximum revenue from the Patient Services segment.

Executives

Awm Investment Company, Inc.

10 percent owner

527 MADISON AVENUE, SUITE 2600, NEW YORK NY 10022